Method for treating HCV
The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the treatment comprises administering at least two direct acting antiviral agents to a subject with HCV infection, wherein the treatment lasts for 12 weeks and does not include administration of either interferon or ribavirin, and said at least two direct acting antiviral agents comprise (a) Compound 1 or a pharmaceutically acceptable salt thereof and (b) Compound 2 or a pharmaceutically acceptable salt thereof.
AbbVie Inc.
A A A A A A A A
A61K A61P A61K A61P A61P A61K A61K A61K
inventional inventional inventional inventional inventional inventional inventional inventional
Rajeev M. Chih-Wei Wei Barry M. Walid M. Sandeep Thomas J. Sven Andrew L. Tianli
Menon Lin Liu Bernstein Awni Dutta Podsadecki Mensing Campbell Wang